Update: Role of the angiotensin type-2 (AT2) receptor in blood pressure regulation

Current Hypertension Reports

Volumn 2, Issue 2, 2000, Pages 198-201

  Carey, Robert M ^a   Wang, Zhi Qin ^a   Siragy, Helmy M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BRADYKININ; CYCLIC GMP; NITRIC OXIDE;

ANIMAL; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; METABOLISM; NATRIURESIS; PHYSIOLOGY; REVIEW;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BRADYKININ; CYCLIC GMP; HUMANS; NATRIURESIS; NITRIC OXIDE; RECEPTORS, ANGIOTENSIN;

EID: 0034170775     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-000-0082-3     Document Type: Article

References (29)

1. Matsukawa T, Ichikawa I: Biological functions of angiotensin and its receptors. Am Rev Physiol 1997, 59: 395-412.
2. Ardaillou R: Angiotensin II receptors. J Am Soc Nephrol 1999, 10: S30-S39.
3. Horiuchi M, Akishita M, Dzau VJ: Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999, 33: 613-621.
4. Ozono R, Wang Z-Q, Moore AG, et al.: Expression of the subtype-2 angiotensin II (AT2) receptor protein in rat kidney. Hypertension 1997, 30: 1238-1246.
5. 2) receptor protein in rat heart. Hypertension 1998, 32: 78-83.
6. 2 receptor subtypes in the rat kidney. Am J Physiol 1999, 277: F437-F446.
7. Nora EH, Munzenmaier DH, Hansen-Smith FM, et al.: Localization of the ANG II type-2 receptor in the micro-circulation of skeletal muscle. Am J Physiol 1998, 275: H1395-H1403.
8. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997, 100: 264-269.
9. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by kinin-dependent mechanisms. Hypertension 1998, 31: 349-355.
10. 2 receptor in a renal wrap hypertension model. Hypertension 1999, 33: 1237-1242.
11. 2) angiotensin receptor. Proc Natl Acad Sci U S A 1999, 96: 6505-6510.
12. Siragy HM, Carey RM: The subtype 2 angiotensin receptor regulates renal prostaglandin F2I formation. Am J Physiol 1997, 273: R1103-R1107.
13. Siragy HM, Senbonmatsu T, Ichiki T, et al.: Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J Clin Invest 1999, 104: 181-188.
14. 2) receptor. Curr Hypertens Rep 1999, 1: 151-157.
15. Arendshorst WJ, Brannstrom K, Ruan X: Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 1999, 10: 5149-5161.
16. 2 receptor: signalling and transport. J Am Soc Nephrol 1999, 10: S69-S74.
17. Arima S, Endo Y, Yaoita H, et al.: Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of the angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 1997, 100: 2816-2823.
18. Endo Y, Arima S, Yaoita H, et al.: Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats. J Vasc Res 1998, 35: 421-427.
19. Cao Z, Denn R, Wu L, et al.: Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertension 1999, 34: 408-414.
20. 2 receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension 1999, 34: 659-665.
21. 2 receptors and cellular localization of subtype mRNAs in human renal cortex using in situ hybridization. Nephron 1998, 80: 25-34.
22. Liu KL, Lo M, Grouzmann E, et al.: The subtype 2 of angiotensin II receptors and pressure-natriuresis in adult rat kidneys. Br J Pharmacol 1999, 126: 826-832.
23. 2 receptor. Kidney Int 2000, 57: 191-202.
24. 2 knockout mice. Biochem Biophys Res Comm 1999, 258: 194-198.
25. Inagami T, Eguchi S, Numaguchi K, et al.: Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases. J Am Soc Nephrol 1999, 10: S57-S61.
26. Tsutumi Y, Matsubara H, Masaki H, et al.: Vascular smooth muscle-targeted over-expression of angiotensin II type 2 receptor causes endothlium-dependent depressor and vasodilative effects via activation of the vascular kinin system. J Clin Invest 1999, 104: 855-864.
27. Searles CD, Harrison DG: The interaction of nitric oxide, bradykinin and the angiotensin II type 2 receptor: lessons learned from transgenic mice. J Clin Invest 1999, 104: 1013-1014.
28. 1 receptor antagonist in hypertensive rats. Hypertension 1999, 34: 1112-1116.
29. 2 receptor induction of bradykinin and nitric oxide mediates valsartan-induced hypotension in conscious rats. Hypertension, in press.